Thank you, Mr. Chair.
Health Canada has the duty and legal responsibility to ensure the safety of pharmaceutical drugs on the Canadian market, and we know that rigorous tests are done before a drug is approved for use in Canada. But the responsibility does not end there. There is also a need to continue monitoring drugs once they are on the market. Indeed, should safety concerns be identified once a drug is available to the public, the need for a quick response is essential to ensure that as few people as possible are exposed to health or safety risks.
Can you explain what steps are being taken to ensure the safety of Canadians in this regard?